Correlation between in vitro cyclic adenosine monophosphate phosphodiesterase inhibition and in vivo anti-inflammatory effect

Skin Pharmacol Appl Skin Physiol. 2000 Mar-Apr;13(2):86-92. doi: 10.1159/000029912.

Abstract

We tested the hypothesis that topical adenosine monophosphate phosphodiesterase (cAMP PDE) inhibitors are anti-inflammatory. These can be shown by a correlation between PDE inhibitory and anti-inflammatory function of a series of known PDE inhibitors. The effect of various cAMP PDE inhibitors on PDEs isolated from HaCaT cells was first investigated. These compounds were then tested as anti-irritants against topical 8% Balsam of Peru. A direct correlation was observed between the in vitro EC(50) values for PDE inhibition and the in vivo anti-inflammatory potential with a correlation coefficient of r = 0.79. These results stress the value of PDE inhibitors as anti-inflammatory agents in topical use, and also demonstrate that the in vitro PDE assay can be used to predict in vivo anti-inflammatory potential.

Publication types

  • Clinical Trial

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
  • Administration, Topical
  • Adult
  • Anti-Inflammatory Agents / pharmacology*
  • Balsams / toxicity
  • Cell Line
  • Cyclic AMP / metabolism
  • Dermatitis, Contact / drug therapy
  • Dermatitis, Contact / pathology
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Irritants / antagonists & inhibitors
  • Irritants / toxicity
  • Middle Aged
  • Skin / drug effects
  • Skin / enzymology*

Substances

  • Anti-Inflammatory Agents
  • Balsams
  • Enzyme Inhibitors
  • Irritants
  • Peruvian balsam
  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases